U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula 2C2H3O2.Ni.4H2O
Molecular Weight 248.8426
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of NICKEL ACETATE TETRAHYDRATE

SMILES

O.O.O.O.[Ni++].CC([O-])=O.CC([O-])=O

InChI

InChIKey=OINIXPNQKAZCRL-UHFFFAOYSA-L
InChI=1S/2C2H4O2.Ni.4H2O/c2*1-2(3)4;;;;;/h2*1H3,(H,3,4);;4*1H2/q;;+2;;;;/p-2

HIDE SMILES / InChI

Molecular Formula H2O
Molecular Weight 18.0153
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula Ni
Molecular Weight 58.6934
Charge 2
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C2H4O2
Molecular Weight 60.052
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Ni acetate is a water soluble salt of Ni, which leads to skin irritation, in particular to allergic contact dermatitis. May cause cancer according to animal studies. Symptoms of overexposure to nickel can cause sensitization, dermatitis, allergic asthma and pneumonitis.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
PubMed

PubMed

TitleDatePubMed
Patents

Sample Use Guides

epithelial tumors in rats: Soluble nickel(II) ion, given to male F344/NCr rats as a single i.p. injection of nickel(II) acetate tetrahydrate at a dose of 90 mumols/kg body weight at 5 weeks of age, proved an effective initiator of renal cortical epithelial tumors
Route of Administration: Intraperitoneal
Human stratum corneum (SC) was prepared by trypsinization of dermatomed cadaver leg skin. The diffusion system included diffusion cells with a spiral line. Aqueous solutions of nickel salts (Ni(NO3)2, NiSO4, NiCl2 and Ni(-OOCCH3)2 at 1% Ni2+ concentration) were used as the donor solution (400 microL/cell). The receptor fluid, pure water, was collected up to 96 h after application of the donor solutions. Nickel concentrations in the donor and receptor fluid, as well as in the SC, were analysed using inductively coupled plasma mass spectrometry (ICP-MS) with a confidence limit of 0.5 ppb. Based on the total recovery of nickel from the experiments, about 98% of the dose remained in the donor solution, whereas 1% or less was retained in SC and less than 1% was found in the receptor fluid. Following an early surge, nickel permeates slowly across SC. The steady-state permeability coefficients of nickel were calculated from the flux data (approximately 5.2-8.5 x 10(-7) cm/h) with no significant difference among the salts. The results concur in principle with earlier studies conducted using the full-thickness human skin in vitro, and suggest that in vivo nickel ions may permeate simultaneously by routes of diffusion such as the shunt pathway, apart from slow transcellular/intercellular diffusion alone.
Substance Class Chemical
Created
by admin
on Sat Dec 16 03:10:14 UTC 2023
Edited
by admin
on Sat Dec 16 03:10:14 UTC 2023
Record UNII
6SOA8L0560
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
NICKEL ACETATE TETRAHYDRATE
Systematic Name English
ACETIC ACID, NICKEL(2+) SALT, HYDRATE (2:1:4)
Common Name English
ACETIC ACID, NICKEL(2+) SALT, TETRAHYDRATE
Common Name English
NICKEL(II) ACETATE TETRAHYDRATE
Systematic Name English
NICKEL ACETATE (NI(OAC)2.4H2O)
Common Name English
NICKEL DIACETATE TETRAHYDRATE
Systematic Name English
NICKEL(2+) ACETATE TETRAHYDRATE
Systematic Name English
Code System Code Type Description
PUBCHEM
62601
Created by admin on Sat Dec 16 03:10:15 UTC 2023 , Edited by admin on Sat Dec 16 03:10:15 UTC 2023
PRIMARY
EPA CompTox
DTXSID9075458
Created by admin on Sat Dec 16 03:10:15 UTC 2023 , Edited by admin on Sat Dec 16 03:10:15 UTC 2023
PRIMARY
CAS
6018-89-9
Created by admin on Sat Dec 16 03:10:15 UTC 2023 , Edited by admin on Sat Dec 16 03:10:15 UTC 2023
PRIMARY
FDA UNII
6SOA8L0560
Created by admin on Sat Dec 16 03:10:15 UTC 2023 , Edited by admin on Sat Dec 16 03:10:15 UTC 2023
PRIMARY
RXCUI
1313175
Created by admin on Sat Dec 16 03:10:15 UTC 2023 , Edited by admin on Sat Dec 16 03:10:15 UTC 2023
PRIMARY RxNorm
Related Record Type Details
ANHYDROUS->SOLVATE